|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$189,361,486 |
|
|
Indirect Value
|
$47,757,584 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$237,119,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-12-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,070,099 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-12-01 |
4 |
AS |
$74.35 |
$5,498,385 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-01-03 |
4 |
OE |
$21.58 |
$1,582,246 |
D/D |
73,337 |
3,204,433 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-01-03 |
4 |
AS |
$73.04 |
$5,396,971 |
D/D |
(73,337) |
3,131,096 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
73,920 |
1,986,683 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
2,024,215 |
0 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
B |
$19.00 |
$1,440,200 |
I/I |
75,800 |
1,952,364 |
2.1 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
78,000 |
4,135,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2005-02-09 |
4 |
S |
$31.50 |
$2,720,425 |
D/D |
(85,000) |
687,014 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2005-02-09 |
4 |
OE |
$4.09 |
$347,973 |
D/D |
85,000 |
772,014 |
|
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-04-01 |
4 |
S |
$42.50 |
$3,923,157 |
D/D |
(92,320) |
1,948,483 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-04-01 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,040,803 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-05-02 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,040,803 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-05-02 |
4 |
S |
$40.04 |
$3,696,622 |
D/D |
(92,320) |
1,948,483 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-06-01 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,040,803 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-06-01 |
4 |
S |
$41.50 |
$3,830,966 |
D/D |
(92,320) |
1,948,483 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-07-01 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,041,535 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-07-01 |
4 |
S |
$41.76 |
$3,855,634 |
D/D |
(92,320) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-08-01 |
4 |
S |
$41.55 |
$3,851,245 |
D/D |
(92,320) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-08-01 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,041,535 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-09-01 |
4 |
S |
$40.07 |
$3,699,013 |
D/D |
(92,320) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-09-01 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,041,535 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-10-10 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,041,535 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-10-10 |
4 |
S |
$40.00 |
$3,693,169 |
D/D |
(92,320) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-01-13 |
4 |
S |
$49.05 |
$4,905,150 |
D/D |
(100,000) |
1,577,253 |
0 |
- |
|
367 Records found
|
|
Page 7 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|